Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs UPRO✓SelectedUSD · UPROGSK vs UPRO performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs UPRO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+60.8%
UPRO return
+186.7%
Excess return
-125.9%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioUPROExcessAlpha
1D-0.1%-5.6%+5.6%+0.4%
7D-1.3%-5.2%+3.9%-0.9%
30D+2.7%-10.8%+13.5%+3.5%
3M+2.7%-16.4%+19.1%+4.0%
6M+3.3%-6.1%+9.4%+3.4%
YTD+6.5%+13.6%-7.1%+4.2%
1Y+10.7%+17.7%-7.0%+8.0%
All+60.8%+186.7%-125.9%+35.9%

Cumulative growth

Daily Returns

Daily percentage return beside UPRO.

Daily Out/Under-Performance

Portfolio return minus UPRO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × UPRO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded UPRO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling